Vol. 5 (05) pp. 1122-1139 DOI: 10.21474/IJAR01/4223

ACCELERATED PARTIAL-BREAST IRRADIATION: A STATE OF THE ART STRATEGY

, , , , , , and
  • PSOC-KSAFH- Radiation Oncology Service.
  • KSAFH- Breast & Endocrine surgery service.
  • PSOC-KSAFH - Medical physics unit.
10 Downloads 112 Views
Crossref

Download Full Paper (PDF)

Abstract

Breast-conserving therapy consists of wide local excision (WLE) followed by whole-breast irradiation (WBI).It is already widely accepted as an alternative to mastectomy. It is used for the treatment of patients with early-stage breast cancer. Accelerated partial-breast irradiation (APBI) is a new strategy. It is characterized by being shorter & an alternative radiation technique for a highly selected patients with favorable early-stage breast cancer. The objective of this review article is to analyze different modalities of APBI delivery and discuss the possible benefits and harms associated with this new platform.

Keywords

Article Analytics

References

  1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-41.
  2. Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707-16.
  3. Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 2001;12:997-1003.
  4. Liljegren G, Holmberg L, Bergh J, et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol. 1999;17:2326-33.
  5. Mukesh M, Harris E, Jena R, et al. Relationship between irradiated breast volume and late normal tissue complications: a systematic review. Radiother Oncol. 2012;104:1-10.
  6. Kuerer HM, Julian TB, Strom EA, Lyerly HK: Accelerated partial breast irradiation after conservative surgery for breast cancer. Ann Surg. 2004, 239: 338-351
  7. Swanson TA, Vicini FA: Overview of accelerated partial breast irradiation. Curr Oncol Rep.2008, 10: 54-60.
  8. Dragun AE, Harper JL, Taylor CE: Patient satisfaction and quality of life after MammoSite breast brachytherapy. Am J Surg. 2008, 196: 545-54
  9. Sher DJ, Wittenberg E, Suh WW: Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis. Int J Radiat Oncol Biol Phys. 2009, 74: 440-446.
  10. Kawase E, Karasawa K, Shimotsu S, et al. Estimation of anxiety and depression in patients with early stage breast cancer before and after radiation therapy. Breast Cancer. 2012;19:147-52.
  11. Whelan TJ, Levine M, Julian J, et al. The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Ontario Clinical Oncology Group. Cancer. 2000;88:2260-6.
  12. Lazovich DA, White E, Thomas DB, Moe RE. Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA. 1991;266:3433-8.
  13. Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med. 1992;326:1097-101.
  14. Athas WF, Adams-Cameron M, Hunt WC, et al. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst. 2000;92:269-71.
  15. Ma AM, Barone J, Wallis AE, et al. Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients. Am J Surg. 2008;196:500-4.
  16. McCarthy EP, Ngo LH, Roetzheim RG, et al. Disparities in breast cancer treatment and survival for women with disabilities. Ann Intern Med. 2006;145:637-45.
  17. Mary Ella Sanders, Troy Scroggins: accelerated Partial Breast Irradiation in Early-Stage Breast Cancer. Journal of Clinical Oncology, Vol 25, No 8 (March 10), 2007: pp. 996-1002
  18. Kahan Z, Csenki M, Varga Z: The risk of early and late lung sequelae after conformal radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys. 2007, 68: 673-681.
  19. Faverly DR, Burgers L, Bult P, Holland R: Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol. 1994, 11: 193-198.
  20. Imamura H, Haga S, Shimizu T: Relationship between the morphological and biological characteristics of intraductal components accompanying invasive ductal breast carcinoma and patient age. Breast Cancer Res Treat. 2000, 62: 177-184.
  21. Veronesi U, Cascinelli N, Mariani L: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med.2002;347:1227?32
  22. Holland R, Veling SH, Mravunac M: Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985, 56: 979-990.
  23. MXiu-peng Ye, Shen Bao:Accelerated Partial Breast Irradiation for Breast Cancer: A meta analysis. Oncology(2013) 6: 619?627
  24. Goyal S, Kearney T, Haffty BG: Current application and research directions for partial-breast irradiation. Oncology (Williston Park). 2007, 21: 449-461.
  25. Sanders ME, Scroggins T: Accelerated partial breast irradiation in early-stage breast cancer. J Clin Oncol. 2007, 25: 996-1002.
  26. Wadasadawala T, Budrukkar A: Quality of life after accelerated partial breast irradiation in early breast cancer: matched pair analysis with protracted whole breast radiotherapy.Clin Oncol(R Coll Radiol).2009,21:668-675
  27. Darby SC, McGale P, Taylor CW, Peto R: Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005, 6: 557-565.
  28. Schaapveld M, Visser O: Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.J Clin Oncol.2008,26:1239-1246.
  29. Schaapveld M, Visser O: The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res Treat. 2008, 110: 189-197.
  30. Arthur DW, Vicini FA: Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol. 2005, 23: 1726-1735.
  31. Offersen BV, Overgaard M, Kroman N, Overgaard J: Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother Oncol. 2009, 90: 1-13.
  32. Zwicker RD, Arthur DW, Kavanagh BD, Mohan R, Schmidt-Ullrich RK: Optimization of planar high-dose-rate implants. Int J Radiat Oncol Biol Phys. 1999, 44: 1171-1177.
  33. Zwicker RD, Schmidt-Ullrich R: Dose uniformity in a planar interstitial implant system. Int J Radiat Oncol Biol Phys. 1995, 31: 149-155.
  34. Kuske RR: Breast brachytherapy. Hematol Oncol Clin North Am. 1999, 13: 543-558.
  35. White JR, Winter KA, Kuske RR, et al. Long-term outcome from RTOG 95-17: a phase I/II study of accelerated partial breast irradiation (APBI) with multicatheter brachytherapy (MCT) following lumpectomy for early-stage breast cancer. J Clin Oncol. 2012;30(Suppl 27):Abstr 147.
  36. Polgar C, Major T, Fodor J, et al, eds. Breast-conserving therapy with partial or whole breast RT: 10-year results of the Budapest randomized trial. World Congress of Brachytherapy; 2012; Barcelona, Spain.
  37. Arthur DW, Vicini FA, Todor DA, et al. Improvements in critical dosimetric endpoints using the Contura multilumen balloon breast brachytherapy catheter to deliver accelerated partial breast irradiation: preliminary dosimetric findings of a phase IV trial. Int J Radiat Oncol Biol Phys. 2011;79:26-33.
  38. Smith GL, Xu Y, Buchholz TA, et al. Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care. J Clin Oncol. 2011;29:157-65.
  39. Niehoff P, Polgar C: Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial. Radiother Oncol. 2006, 79: 316-320.
  40. Dragun AE, Harper JL: Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys. 2007, 68: 354-358.
  41. Vicini F, Beitsch PD: Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer. 2008, 112: 758-766.
  42. Benitez PR, Keisch ME et al: Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg. 2007, 194: 456-462.
  43. Dickler A, Patel RR, Wazer D: Breast brachytherapy devices. Expert Rev Med Devices. 2009, 6: 325-333.
  44. Scanderbeg DJ, Yashar C : Evaluation of Three APBI Techniques Under NSABP B-39 Guidelines. J Appl Clin Med Phys. 2010, 11: 3021
  45. Scanderbeg DJ, Yashar C, Rice R, Pawlicki T: Clinical implementation of a new HDR brachytherapy device for partial breast irradiation.Radiother Oncol.2009, 90: 36-42
  46. Vicini F, Beitsch P, Quiet C, et al. Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2011;79:808-17.
  47. Khan AJ, Arthur D, Vicini F, et al. Six-year analysis of treatment-related toxicities in patients treated with accelerated partial breast irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy registry trial. Ann Surg Oncol. 2012;19:1477-83.
  48. Smith GL, Xu Y, Buchholz TA, et al. Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer. JAMA. 2012;307:1827-37.
  49. Presley CJ, Soulos PR, Herrin J, et al. Patterns of use and short-term complications of breast brachytherapy in the national Medicare population from 2008-2009. J Clin Oncol. 2012;30:4302-7.
  50. Abbott AM, Habermann EB, Tuttle TM. Trends in the use of implantable accelerated partial breast irradiation therapy for early stage breast cancer in the United States. Cancer. 2011;117:3305-10.
  51. Baglan KL, Sharpe MB, Jaffray D, et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2003;55:302-11.
  52. Kozak KR, Doppke KP, Katz A, Taghian AG: Dosimetric comparison of two different three-dimensional conformal external beam accelerated partial breast irradiation techniques. Int J Radiat Oncol Biol Phys. 2006, 65: 340-346.
  53. Vicini F, Winter K, Wong J: Initial Efficacy Results of RTOG 0319: Three-Dimensional Conformal Radiation Therapy (3D-CRT) Confined to the Region of the Lumpectomy Cavity for Stage I/II Breast Carcinoma. Int J Radiat Oncol Biol Phys. 2010, 77: 1120-1127
  54. Vicini FA, Chen P et al: Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2007, 69: 1124-1130.
  55. Chen PY, Wallace M : Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2010, 76: 991-997.
  56. Taghian AG, El-Din MA: Interim results of a phase I/II trial of 3D-conformal external beam accelerated partial breast irradiation in patients with early breast cancer.Int J Radiat Oncol Biol Phys. 2008,72:S4-S4.
  57. Hepel JT, Tokita M: Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2009, 75: 1290-1296.
  58. Formenti SC, Rosenstein B: T1 stage breast cancer: adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients-pilot feasibility study. Radiology. 2002, 222: 171-178.
  59. Bush DA, Do S, Lum S, Garberoglio C: Partial breast radiation therapy with proton beam: 5-year results with cosmetic outcomes. Int J Radiat Oncol Biol Phys. 2014;90:501?5
  60. Vicini F, Winter K, Wong J, et al. Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/ II breast carcinoma. Int J Radiat Oncol Biol Phys. 2010;77:1120-7.
  61. Whelan TJ, Olivotto I, Parpia S, et al. Interim toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation (APBI) using 3D conformal external beam radiation therapy (3D CRT). Int J Radiat Oncol Biol Phys. 2013;85:21-22.
  62. Taghian AG, Kozak KR, Katz A, et al. Accelerated partial breast irradiation using proton beams: Initial dosimetric experience. Int J Radiat Oncol Biol Phys. 2006;65:1404-10.
  63. Kozak KR, Smith BL, Adams J, et al. Accelerated partial-breast irradiation using proton beams: initial clinical experience. Int J Radiat Oncol Biol Phys. 2006;66:691-8.
  64. Bush DA, Slater JD, Garberoglio C, et al. Partial breast irradiation delivered with proton beam: results of a phase II trial. Clin Breast Cancer. 2011;11:241-5.
  65. Vaidya JS, Joseph DJ, Tobias JS, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet. 2010;376:91-102.
  66. Orecchia R. ELIOT Trials in Milan: Results. World Congress of Brachytherapy; Barcelona, Spain. 2012.
  67. Khan AJ, Dale RG, Arthur DW, et al. Ultrashort courses of adjuvant breast radiotherapy: wave of the future or a fool's errand? Cancer. 2012;118:1962-70.
  68. Holmes DR, Baum M, Joseph D: The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update). Am J Surg. 2007, 194: 507-510
  69. Vaidya JS, Tobias JS, et al: Intraoperative radiotherapy for breast cancer. Lancet Oncol. 2004, 5: 165-173.
  70. Kraus-Tiefenbacher U, Scheda A: Intraoperative radiotherapy (IORT) for breast cancer using the Intrabeam system. Tumori. 2005, 91: 339-345.
  71. Orecchia R, Luini A: Electron intraoperative treatment in patients with early-stage breast cancer: data update. Expert Rev Anticancer Ther. 2006, 6: 605-611.
  72. Mussari S, Sabino Della Sala W: Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience. Strahlenther Onkol. 2006, 182: 589-595.
  73. Karni T, Pappo I, Sandbank J: A device for real-time, intraoperative margin assessment in breast-conservation surgery. Am J Surg. 2007, 194: 467-473.
  74. Vaidya JS, Tobias JS, Baum M, et al. Intraoperative radiotherapy for breast cancer. Lancet Oncol. 2004;5:165-73.
  75. Bartelink H, Horiot JC, Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol. 2007; 25:3259-65.
  76. Rosenstein BS, Lymberis SC, Formenti SC. Biologic comparison of partial breast irradiation protocols. Int J Radiat Oncol Biol Phys. 2004;60:1393-404.
  77. Bentzen SM, Yarnold JR. Reports of unexpected late side effects of accelerated partial breast irradiation? radiobiological considerations. Int J Radiat Oncol Biol Phys. 2010;77:969-73.
  78. Faverly DR, Hendriks JH, Holland R. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer. 2001;91:647-59.
  79. Nguyen BT, Deb S, Fox S, et al. A prospective pathologic study to define the clinical target volume for partial breast radiation therapy in women with early breast cancer. Int J Radiat Oncol Biol Phys. 2012;84:1116-22.
  80. Cuttino LW, Todor D, Pacyna L, et al. Three-dimensional conformal external beam radiotherapy (3D-CRT) for accelerated partial breast irradiation (APBI): what is the correct prescription dose? Am J Clin Oncol. 2006;29:474-8.
  81. Chen PY, Vicini FA, Benitez P, et al. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer. 2006;106:991-9.
  82. Polgar C, Sulyok Z, Fodor J, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol. 2002;80:121-8; discussion 29.
  83. Wazer DE, Lowther D, Boyle T, et al. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer.Int J Radiat Oncol Biol Phys.2001;50:107-11.
  84. Albuquerque K, Tell D, Lobo P, et al. Impact of partial versus whole breast radiation therapy on fatigue, perceived stress, quality of life and natural killer cell activity in women with breast cancer. BMC Cancer. 2012;12:251.
  85. Hattangadi J, Taback N, Neville BA, et al. Accelerated partial breast irradiation using brachytherapy for breast cancer: patterns in utilization and guideline concordance.J Natl Cancer Inst.2012;104:1-13
  86. Suh WW, Pierce LJ, Vicini FA, Hayman JA. A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2005;62:790-6.
  87. Sher DJ, Wittenberg E, Suh WW, et al. Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis. Int J Radiat Oncol Biol Phys. 2009;74:440-6.
  88. Shah C, Lanni TB, Saini H, et al. Cost-efficacy of acceleration partial-breast irradiation compared with whole-breast irradiation. Breast Cancer Res Treat. 2013;138:127-35.
  89. Lanni T, Keisch M, Shah C, et al. A cost comparison analysis of adjuvant radiation therapy techniques after breast-conserving surgery. Breast J. 2013;19:162-7.
  90. Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74:987-1001.
  91. Polgar C, Van Limbergen E, Potter R, et al. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol. 94:264-73.
  92. Board of Directors ASoBS. Consenus statement for accelerated partial breast irradiation. 2011. Accessed March 26, 2013.
  93. Breast Brachytherapy Task Group, ABS. ABS Breast Brachytherapy Task Group. 2007. Accessed March 26, 2013.
  94. NCCN (National Comprehensive Cancer Network) Guidelines of Breast Cancer (2015).
  95. AIRO associazione:la radioterapia dei tumori della Mammella Indicazione e Criteria Guida 2013.
  96. Smith BD, Arthur DW,et al: Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology(ASTRO).Int J Radiat Oncolo Biol Phys.2009,74:987-1001
  97. Polgar C, Van Limbergen E, et al: Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Europeen de Curietherapie-European Society for
  Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol. 2010, 94: 264-273.
  1. Vicini F, Arthur D, Wazer D, et al. Limitations of the American Society of Therapeutic Radiology and Oncology Consensus Panel guidelines on the use of accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2011;79:977-84.
  2. Shaitelman SF, Vicini FA, Beitsch P, et al. Five-year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breast Surgeons MammoSite Registry
Trial. Cancer.2010;116:4677-85.
  1. Wolmark N, Curran W. NSABP Protocol B-39. RTOG Protocol 0413. A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer. 2011.
  2. Coles C, Yarnold J. The IMPORT trials are launched (September 2006). Clin Oncol (R Coll Radiol). 2006;18:587-90.
  3. Yarnold J. Randomised trial testing intensity modulated and partial organ radiotherapy after breast conservation surgery for early breast cancer. 2008 [updated January 6, 2011]. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00814567. Accessed March 26, 2013.
  4. Strnad V, Polg?r, C. Interstitial brachytherapy alone versus external beam radiation therapy after breast conserving surgery for low risk invasive carcinoma and low risk duct carcinoma in-situ (DCIS) of the female breast.
  5. Frezza G, Bertoni, F. IRMA. Breast cancer with low risk of local recurrence: partial and accelerated radiation with three-dimensional conformal radiotherapy (3DCRT) vs. standard radiotherapy after conserving surgery (phase III study). 2007.
  6. Danish Breast Cancer Cooperative Group. Partial breast versus whole breast irradiation in elderly women operated on for early breast cancer. 2011.
  7. Belkacemi Y, Lartigau, E. Standard or hypofractionated radiotherapy versus accelerated partial breast irradiation (APBI) for breast cancer (SHARE). 2011.
  8. Livi L, Buonamici FB, Simontacchi G, et al. Accelerated partial breast irradiation with IMRT: new technical approach and interim analysis of acute toxicity in a phase III randomized clinical trial. Int J Radiat Oncol Biol Phys. 77:509-15.
  9. Schmitz AC, Pengel KE, Loo CE, et al. Pre-treatment imaging and pathology characteristics of invasive breast cancers of limited extent: potential relevance for MRI-guided localized therapy. Radiother Oncol. 2012;104:11-8.
  10. Palta M, Yoo S, Adamson JD, et al. Preoperative single fraction partial breast radiotherapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2012;82:37-42.
  11. Dorn PL, Al-Hallaq HA, Haq F, et al. A prospective st6dy of the utility of magnetic resonance imaging in determining candidacy for partial breast irradiation.Int J Radiat Oncol Biol Phys.2013;85:615-22.

How to Cite This Article

Ebtesam Hamoud, Ismail Ghorbel, Keyan Falfali1, Attiya Bin Mohammad Al Zahrani, Yousef Al Alawi, Sharif Qatarneh, Omar Alzahrani and Mostafa Abdelrahman. (2017); ACCELERATED PARTIAL-BREAST IRRADIATION: A STATE OF THE ART STRATEGY, Int. J. of Adv. Res., 5 (05), 1122-1139, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/4223

Corresponding Author

DR RASHID MIR
Assistant Professor, Prince Fahd Bin Sultan Research chair
Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.